Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotrastaurin and Binimetinib in Metastatic Uveal Melanoma
NCT01801358Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of sotrastaurin in Uveal melanoma (UM), sponsored by Pfizer. Started Aug 2013; status: terminated.
02
Drugs
sotrastaurin
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT01801358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01801358.